Workflow
大宗氨基酸
icon
Search documents
「微元合成」获近3亿元融资,以甲醇为原料、开发大宗生物基产品|早起看早期
36氪· 2026-01-08 00:10
Core Viewpoint - "Micro Yuan Synthesis" has recently secured nearly 300 million yuan in a new round of equity financing, with the funds primarily aimed at accelerating the research and development of methanol-based bio-manufacturing of bulk bio-based products [1][2]. Group 1: Company Developments - "Micro Yuan Synthesis" has successfully developed and industrialized several human and animal nutrition products, including allulose, lutein, and mannitol [1]. - The company has achieved significant commercial progress in the development of core products like allulose, becoming the first in China to receive administrative approval for allulose production through a biological fermentation process [1][2]. - A strategic partnership has been established with Cargill, focusing on the promotion and production collaboration of allulose and other sugar-reducing products [2]. Group 2: Industry Context - The global production of chemical products is approximately 2.3 billion tons annually, while bio-based products account for only 180 million tons, indicating a significant gap and potential for growth in bio-manufacturing [4]. - The development of non-grain bio-based products is essential, particularly using alternative carbon sources like straw and CO2, to address the challenges of raw material costs in bio-manufacturing [4]. - Methanol is identified as an ideal alternative carbon source, with China's coal-based methanol production capacity exceeding 10 million tons, representing 67% of the global total, and facing overcapacity issues [4].
3亿元融资!微元合成加速推进甲醇生物制造大宗生物基产品
Core Viewpoint - The article emphasizes the importance of "non-grain" raw materials in the future of the bio-manufacturing industry, highlighting the recent funding round of nearly 300 million yuan for Weiyuan Synthesis to accelerate the development of methanol-based bio-manufactured products [2][3]. Group 1: Industry Trends - The bio-manufacturing sector is positioned as a key driver for future industrial transformation, with McKinsey predicting that 60% of global material production could be synthesized biologically [2]. - The current reliance on starch sugars for bio-based products poses a risk of "competing with food" due to the high demand for agricultural resources, which contradicts the goals of sustainable development [2][3]. Group 2: Methanol Production and Capacity - China's methanol production capacity has rapidly expanded, exceeding 100 million tons, with an additional 100 million tons planned, primarily from coal, which accounts for 80% of production [4][5]. - The development of green methanol production using renewable energy sources is gaining traction, with plans for 6 million tons of green methanol capacity by mid-2025, which could support the bio-manufacturing sector and contribute to carbon neutrality goals [5]. Group 3: Weiyuan Synthesis Developments - Weiyuan Synthesis has successfully developed high-efficiency strains for assimilating methanol and is advancing its pipeline for bio-manufactured products, including bulk amino acids and bio-based materials [7]. - This innovation addresses the raw material challenges in bio-manufacturing and helps mitigate the domestic surplus of methanol, while also reducing reliance on imported soybean meal, thereby enhancing food security [7].
「微元合成」获近3亿元融资,以甲醇为原料、开发大宗生物基产品 | 36氪首发
3 6 Ke· 2026-01-04 00:08
Group 1 - The core viewpoint of the article is that "微元合成" has recently secured nearly 300 million yuan in a new round of equity financing, with the funds aimed at accelerating the research and development of methanol-based biomanufacturing products [1][2] - The company has made significant progress in the development and commercialization of human and animal nutrition products, including allulose, lutein, and mannitol [1] - The financing will focus on the strategic area of "methanol biomanufacturing," with the company having already developed multiple high-efficiency methanol-assimilating strains [2][3] Group 2 - The company has received administrative approval from the National Health Commission for the production of allulose through a unique fermentation process, making it the first in China to do so [1][2] - The innovative "one-step fermentation method" simplifies the production process and significantly reduces costs compared to traditional methods [2] - The global production of chemical products is approximately 2.3 billion tons annually, while biobased products account for only 180 million tons, highlighting the need for non-food carbon sources in biomanufacturing [3] Group 3 - Methanol is identified as an ideal alternative carbon source, with China's coal-to-methanol capacity exceeding 10 million tons, representing 67% of the global total [3] - The company aims to utilize methanol to produce bulk amino acids, thereby reducing reliance on imported soybean meal and ensuring food security [3] - The development of non-food biobased products, particularly using agricultural residues and carbon dioxide, is gaining industry attention despite challenges in cost and logistics [3]